← Evidence map

ArticleClinical epigenetics2025

Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients.

Halka Lhotska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39881389